A Research Study, Looking at How Ryzodeg® (Insulin Degludec/Insulin Aspart) Works in People With Type 2 Diabetes in Local Clinical Practice

NCT04042441 · clinicaltrials.gov ↗

COMPLETED

Status

1122

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin Degludec/Insulin Aspart

Sponsor

Novo Nordisk A/S